# Effects of Huperzine a on Presbycusis(Δ,kHz, DB,MMSE, AD)

> **NCT03101722** · NA · ENROLLING_BY_INVITATION · sponsor: **Zhijun Bao** · enrollment: 60 (estimated)

## Conditions studied

- Presbycusis
- Tinnitus
- Cognitive Impairment

## Interventions

- **DRUG:** BTHE and Huperzine A
- **OTHER:** BETH

## Key facts

- **NCT ID:** NCT03101722
- **Lead sponsor:** Zhijun Bao
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2017-05-15
- **Primary completion:** 2030-09-15
- **Final completion:** 2030-09-15
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2024-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03101722

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03101722, "Effects of Huperzine a on Presbycusis(Δ,kHz, DB,MMSE, AD)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03101722. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*